SILVER SPRING, Md. and SINGAPORE, Singapore, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology provider of cell and gene therapy solutions, announced today its wholly-owned subsidiary, Austrianova Singapore Pte Ltd (ASPL) has just received notice that the U.S. based Personal Care Products Council (PCPC) has assigned the International Nomenclature Cosmetic Ingredient (INCI) name Gel8 (pronounced gelate), to the company's proprietary cell encapsulation materials.
The PCPC determined, through the International Nomenclature Committee, to provide the Gel8 name assignment to ASPL. As a result, Gel8 will now be included as a new product in the International Cosmetic Ingredient Dictionary & Handbook as well as in the next update of the Cosmetic industry's International Buyer's Guide. The combined Dictionary/Handbook contains more than 19,100 INCI labeling names for the United States, European Union, Japan and other countries. There are many aspects of cosmetics safety and labeling overseen by the FDA and other regulatory bodies around the world. Receiving the INCI designation allows for greater potential use in cosmetics throughout the US and the world.
Dr. John Dangerfield, Chief Operating Officer of ASPL, said, "We are thrilled that our work has enabled us to receive this designation. Most importantly, holding the INCI name is necessary for product safety and visibility as well as a significant step forward for using the Cell-in-a-Box® and Bac-in-a-Box® technology throughout the cosmetics industry. We see applications of the technology that expand from the cancer field well into other areas of medicine, cosmetics, and nutrition, among others, and see this designation as one of the first important steps."The Chief Executive of Nuvilex, Dr. Robert Ryan, stated, "I was extremely impressed by what I saw while visiting ASPL in Singapore last week. I'm certain the effort they put forward to receive assignment of the INCI name Gel8 for our live cell components from our Cell-in-a-Box® and Bac-in-a-Box® patented encapsulation technology from the Personal Care Products Council is a significant move forward. All of the effort by the lab over the past year will allow us to expand the use of the technology and ultimately be able to produce products for other markets including the cosmetics market. The ability to receive the INCI designation also demonstrates how broad this platform technology we are developing together with ASPL is."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV